Presentation
PEP-Therapy is a French clinical stage biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell Penetrating and Interfering Peptides (CP&IP) technology. These innovative molecules penetrate cells and specifically block relevant intracellular protein-protein interactions, leading to the inhibition of key pathological mechanisms without altering physiological mechanisms.
Contact
hello.pep@pep-therapy.com
Address
29 rue du Faubourg Saint Jacques, PARIS 75014
Website
Targeting innovation : Breast cancer, Gynecological cancers